This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Heidelberg Biotech Gmbh. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Amir Abdollahi: Innovator in Protein Oligomer Research
Introduction
Amir Abdollahi is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of protein oligomers for medical applications. With a total of 4 patents, his work focuses on innovative methods for treating diseases related to angiogenesis, fibrosis, and cancer.
Latest Patents
Abdollahi's latest patents include groundbreaking inventions aimed at addressing critical health issues. One of his patents, titled "Means and methods for the treatment of angiogenesis-, fibrosis- and cancer-related diseases with protein oligomers comprising NC-1-Fc," details a method for producing a protein oligomer that includes heterodimeric human NC-1-Fc proteins. This method involves culturing host cells to create a specific protein oligomer that can potentially be used in therapeutic applications.
Another significant patent is "Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases." This invention describes a protein oligomer that can be utilized for treating, ameliorating, or preventing fibrosis and related diseases. It also has diagnostic applications for detecting these conditions, showcasing the versatility and importance of his research.
Career Highlights
Throughout his career, Amir Abdollahi has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum and Heidelberg Biotech GmbH. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research.
Collaborations
Abdollahi has collaborated with notable colleagues, including Jürgen Debus and Kashi Javaherian. These partnerships have further enhanced his research capabilities and have led to advancements in the understanding of protein oligomers and their applications in medicine.
Conclusion
Amir Abdollahi's innovative work in the field of protein oligomers has the potential to significantly impact the treatment of various diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile